Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial

Jian-wei Li,1,2,* Guang-yu Liu,1,2,* Ya-jie Ji,3,* Xia Yan,1,2 Da Pang,4 Ze-fei Jiang,5 De-dian Chen,6 Bin Zhang,7 Bing-he Xu,8 Zhi-ming Shao1,2 1Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Department of Oncology, Shanghai M...

Full description

Bibliographic Details
Main Authors: Li J, Liu G, Ji Y, Yan X, Pang D, Jiang Z, Chen D, Zhang B, Xu B, Shao Z
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:Cancer Management and Research
Subjects:
Breast cancer
adjuvant therapy
anastrozole
tamoxifen
GnRH analogs
aromatase inhibitors
Online Access:https://www.dovepress.com/switching-to-anastrozole-plus-goserelin-vs-continued-tamoxifen-for-adj-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/switching-to-anastrozole-plus-goserelin-vs-continued-tamoxifen-for-adj-peer-reviewed-article-CMAR

Similar Items